SEC Form 4 · accession 0001387131-16-008362
Corindus Vascular Robotics, Inc. · CVRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark J Toland
Officer — President and CEO · Director
Period of report
Dec 1, 2016
Accepted (ET)
Dec 5, 2016 · 9:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528557
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified stock optionF1 | $1.46 | Dec 1, 2016 | A | 297,335 | A | Dec 1, 2016 | Mar 6, 2026 | Common Stock | 297,335 | 297,335 | D |
| Non-qualified stock optionF2 | $0.70 | Dec 1, 2016 | A | 297,335 | A | Dec 1, 2016 | Nov 30, 2026 | Common Stock | 297,335 | 297,335 | D |
Explanation of responses
- F1Mr. Toland was granted this performance-based option on March 7, 2016 pursuant to his Employment Agreement dated February 23, 2016. The option vested in full on December 1, 2016 upon the Board's determination that Mr. Toland achieved the required performance criteria, which was his relocation to the Boston area.
- F2Mr. Toland was granted this option on December 1, 2016 pursuant to his Employment Agreement dated February 23, 2016. This option was fully vested on the December 1, 2016 grant date as the criteria for this grant, the recruitment and hiring of the senior leadership team, was deemed satisfied by the Board.